Acquiring Big Pharma Venture Capital For Your Digital Health Concept
Over the past five years, major pharmaceutical corporations, through their separate venture capital investment organizations, have increasingly invested in small digital health development companies. Major pharmaceutical corporations, in fact, are actively using their tremendous wealth to invest in start ups and small emerging firms producing innovative technologies for the healthcare market. The corporations, moreover, are stepping out of their traditional roles as drug makers and acting as a serious alternative funder for aspiring health technology developers.
This Skype presentation offers you an opportunity to learn how your start up or small emerging firm can acquire private investment capital from pharmaceutical, aka Big Pharma, venture funds to produce an innovative, problem-solving digital health technology solution. In particular, you will learn, among other things, the following:
* What type of digital health projects are funded by pharmaceutical venture funds.
* What business development stages are funded by pharmaceutical venture funds.
* What funding amounts the pharmaceutical venture funds offer.
* The names of the most active pharmaceutical venture funds investing digital health technologies.
* How to position your company to acquire capital investment from the pharmaceutical venture funds.
This session is based on Eighteen Ventures' upcoming information brief: Acquiring Pharma Venture Capital For Your Digital Health Concept
Date: Wednesday, July 24th, 2019
Time: 11:00 AM - 12:00 PM Eastern Standard Time (EST). NOTE: Participants will be able to connect into the event at 10:40 AM.
Registration Deadline: 8:00 PM ET on Monday, 22nd July , 2019. No registrations will be accept after this deadline.
Registration Process: Please complete and submit the Registration form below. Your registration will be confirmed with an e-mail from Eighteen Ventures.
Who Benefits Most From Attending: Entrepreneurs, CEOs, start up and small emerging firms owners, National Science Foundation (NSF) and National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase I & II award winner.
About the Presenter: Darrell Williams is an experienced small business development consultant who has been involved in the Small Business Innovation Research (SBIR) program since 1999. Darrell is the Founder, President and CEO of Eighteen Ventures, and has authored numerous publications about SBIR funding; as well as Venture Capitalists, Business Angels, and Corporate Venture Capitalists.
Contact: Mr. Darrell Williams, Darrell@eighteenventures.com or (305) 322-2443.